Gestational diabetes mellitus: Case definition guidelines for data collection, analysis, and presentation of immunization safety data.
Por:
Kachikis A, Eckert LO, Walker C, Oteng-Ntim E, Guggilla R, Gupta M, Patwardhan M, Mataya R, Mallett Moore T, Alguacil-Ramos AM, Keech C, Gravett M, Murphy H, Kochhar S, Chescheir N and Brighton Collaboration Gestational Diabetes Mellitus Working Group
Publicada:
4 dic 2017
Resumen:
Filiaciones:
Kachikis A:
University of Washington, Seattle, WA, USA
Eckert LO:
University of Washington, Seattle, WA, USA
Walker C:
University of Washington, Seattle, WA, USA
Oteng-Ntim E:
London School of Hygiene and Tropical Medicine, UK
King's College London, UK
Guggilla R:
George Institute for Global Health, India
Gupta M:
Barts Health NHS Trust, London, UK
Patwardhan M:
Wayne State University, USA
Mataya R:
Loma Linda University, USA
University of Malawi College of Medicine, Malawi
Mallett Moore T:
Sanofi Pasteur, USA
:
Dirección General de Salud Pública, Conselleria de Sanidad Universal y Salud Pública, Spain
Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO), Spain
Keech C:
PPD, USA
Gravett M:
University of Washington, Seattle, WA, USA
Global Alliance to Prevent Prematurity and Stillbirth, An Initiative of Seattle Children's Hospital, USA
Murphy H:
University of East Anglia/Cambridge University Hospitals NHS Foundation Trust, UK
Kochhar S:
Global Healthcare Consulting, Delhi, India
Erasmus University Medical Center, Rotterdam, The Netherlands
Chescheir N:
University of North Carolina, Chapel Hill, USA
|